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ABSTRACT
Mouse hepatitis virus (MHV) isolates JHM.WU and JHM.SD promote severe central nervous system disease. However, while
JHM.WU replicates robustly and induces hepatitis, JHM.SD fails to replicate or induce pathology in the liver. These two JHM
variants encode homologous proteins with few polymorphisms, and little is known about which viral proteins(s) is responsible
for the liver tropism of JHM.WU.We constructed reverse genetic systems for JHM.SD and JHM.WU and, utilizing these full-
length cDNA clones, constructed chimeric viruses andmapped the virulence factors involved in liver tropism. Exchanging the
spike proteins of the two viruses neither increased replication of JHM.SD in the liver nor attenuated JHM.WU. By further map-
ping, we found that polymorphisms in JHM.WU structural proteinM and nonstructural replicase proteins nsp1 and nsp13 are
essential for liver pathogenesis. M protein and nsp13, the helicase, of JHM.WU are required for efficient replication in vitro and
in the liver in vivo. The JHM.SD nsp1 protein contains a K194R substitution of Lys194, a residue conserved among all other
MHV strains. The K194R polymorphism has no effect on in vitro replication but influences hepatotropism, and introduction of
R194K into JHM.SD promotes replication in the liver. Conversely, a K194R substitution in nsp1 of JHM.WU or A59, another
hepatotropic strain, significantly attenuates replication of each strain in the liver and increases IFN- expression in macro-
phages in culture. Our data indicate that both structural and nonstructural proteins contribute to MHV liver pathogenesis and
support previous reports that nsp1 is a Betacoronavirus virulence factor.
IMPORTANCE
The Betacoronavirus genus includes human pathogens, some of which cause severe respiratory disease. The spread of severe
acute respiratory syndrome coronavirus (SARS-CoV) andMiddle East respiratory syndrome coronavirus (MERS-CoV) into hu-
man populations demonstrates the zoonotic potential of emerging coronaviruses, and there are currently no vaccines or effective
antivirals for human coronaviruses. Thus, it is important to understand the virus-host interaction that regulates coronavirus
pathogenesis. Murine coronavirus infection of mice provides a useful model for the study of coronavirus-host interactions, in-
cluding the determinants of tropism and virulence. We found that very small changes in coronavirus proteins can profoundly
affect tropism and virulence. Furthermore, the hepatotropism of MHV-JHM depends not on the spike protein and viral entry
but rather on a combination of the structural proteinM and nonstructural replicase-associated proteins nsp1 and nsp13, which
are conserved among betacoronaviruses. Understanding virulence determinants will aid in the design of vaccines and antiviral
strategies.
Mouse hepatitis virus (MHV) is an enveloped, nonsegmented,positive-strand RNA virus that belongs to the orderNidovi-
rales, family Coronaviridae, and genus Betacoronavirus (1). Beta-
coronaviruses can have significant effects on human (2) and ani-
mal (3) health.Most notably, the emergent pathogens severe acute
respiratory syndrome coronavirus (SARS-CoV) and Middle East
respiratory syndrome coronavirus (MERS-CoV) cause severe re-
spiratory disease with significant mortality (4). Thus, it is impor-
tant to understand the coronavirus-encoded determinants of tro-
pism and virulence. MHV is a model coronavirus that infects the
livers and brains of laboratory mice, causing acute hepatitis, en-
cephalitis, and chronic demyelinating disease in an MHV strain-
specificmanner (5).We useMHV infection of themouse to study
the virus and host determinants of pathogenesis during infection
of the liver and central nervous system (CNS).
Previous studies demonstrated that both viral spike protein-
mediated entry and non-spike-associated postentry events signif-
icantly influenceMHV tropism. For example, a single Q159L sub-
stitution within the amino-terminal receptor-binding domain of
the S1 subunit of the spike protein of the dualtropic A59 strainwas
sufficient to abrogate hepatotropism but had little effect on CNS
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pathogenesis, and hepatotropic revertants had compensatorymu-
tations in the heptad repeat domain of the S2 subunit (6). A long
hypervariable domain within the amino-terminal spike subunit
S1 has been associated with the ability to spread independently of
the viral receptor CEACAM1a and with the high neurovirulence
of the JHM.SD strain (7). Substitutions within the heptad repeat
domains of the spike have caused defects in spike-induced cell-to-
cell fusion and limited spread in the brain (8, 9). In addition, the
replicase and other nonstructural proteins have also been identi-
fied as liver virulence factors. A mutation within the ADP-ribose-
1-phosphatase (ADRP), the macrodomain of the nsp3 protein,
that abolished enzymatic activity attenuated hepatitis compared
to wild-type (wt) virus but did not significantly reduce replication
in the liver (10), and it recently was found to reduce replication
and pathogenesis in theCNS (11). Accessory protein ns2 is a 2=,5=-
phosphodiesterase (PDE) that cleaves 2=,5=-oligoadenylates,
thereby blocking the activation of RNase L. Mutation of ns2 abol-
ishes PDE activity and attenuates viral replication in the liver and
the consequent hepatitis without substantially affecting CNS in-
fection (12).
The JHM.SD isolate of MHV is highly neurovirulent but fails
to replicate in the liver and cause hepatitis evenwhen inoculated at
doses as high as 105 PFU (13); in contrast, the dualtropic (highly
neurotropic/highly hepatotropic) JHM.WU replicates to very
high titer in the liver (14). JHM.SD encodeswild-type nsp3-ADRP
and ns2-PDE but still does not cause hepatitis, suggesting that
additional proteins mediate liver pathogenicity. In order to iden-
tify such virulence determinants, we used a reverse genetic ap-
proach and constructed full-length cDNA clones representing
JHM.WU (14, 15) and JHM.SD (16). By exchanging fragments of
the genomes and constructing site-directedmutants, we identified
the nsp1, nsp13, and M proteins as contributors to JHM replica-
tion in the liver.
MATERIALS AND METHODS
Cell lines, mice, and viruses. Recombinant JHM.SD (RJHM/A) (13, 16),
which was based on the MHV-4 isolate of JHM (16) and previously re-
covered by RNA-targeted recombination, and JHM.WU (previously
called wb-3) (14, 15) were used as templates to generate infectious cDNA
clones. Mildly neurotropic and moderately hepatotropic recombinant
rA59 was derived from an existing infectious cDNA clone (17, 18). The
mouse 17Cl-1 and L2 fibroblast cell lines and baby hamster kidney cells
constitutively expressing MHV receptor CEACAM-1 (BHK-MHVR)
were cultured as described previously (17, 19). Primary bone marrow-
derived macrophages (BMM) were generated from the hind limbs of B6
or type I interferon receptor-deficient (IFNAR/)mice as described pre-
viously and cultured in Dulbecco modified Eagle medium (DMEM) sup-
plemented with 10% fetal bovine serum (FBS), 1 mM pyruvate, and 30%
L929 cell-conditioned medium for 6 days before infection (20). BMM
cultures were routinely 99% pure as assessed by positive staining for
expression of CD11b and negative staining for expression of CD11c.
C57BL/6 (B6) mice were purchased from the National Cancer Institute
(Frederick, MD) and bred in the University of Pennsylvania animal facil-
ity according to procedures approved by the University IACUC.
Construction of JHM.SD and JHM.WU infectious cDNA clones.
The strategy employed to construct the infectious cDNA clone of JHM.SD
was as described previously for A59 (17) with slight modification. Intra-
cellular RNA was extracted from recombinant JHM.SD (RJHM/A)-in-
fected 17Cl-1 cells and reverse transcribed using SuperScript II (Invitro-
gen, Carlsbad, CA) and random hexamer primers. The cDNA was
amplified by PCR with Expand Long TAQ polymerase (Roche, Mann-
heim, Germany) to create six fragments (A to F) (Fig. 1). Fragment A was
cloned into pCR4 TOPOTA (Invitrogen) and fragments B through F into
pSMART-LCAmp (Lucigen). Fragment G was derived from viral se-
quences in pJHM (21), which were modified to add a BsmBI site at the 5=
end. All of the BsmBI restriction sites encoded within the genome were
removed by PCR-based site-directedmutagenesis. BsmB1 restriction sites
flanking each of the fragments, as well as the EcoRV site at the 5= end of
fragment A and the PacI site at the 3= end of fragment G, were introduced
during the construction and were used for full-length in vitro genome
assembly (Fig. 1).
The infectious JHM.WU cDNA clone was constructed using the
JHM.SD fragments as a scaffold. Fragments A, C, F, and G were PCR
amplified from intracellular RNA extracted from JHM.WU (wb-3)-in-
fected 17Cl-1 cells (15) and inserted into the JHM.SD plasmids in place of
the corresponding fragments. The endogenous BsmBI sites were removed
as for JHM.SD (Fig. 1). JHM.SD fragments B, D, and E were used for
JHM.WUbecause the proteins encoded by these fragments have complete
amino acid sequence identity between the two isolates. All of the primers
used for plasmid construction and mutation are available upon request.
All of the chimeric andmutant clones used for virus recoverywere verified
by nucleotide sequencing. A schematic diagram of the construction of the
rJHM.SD and rJHM.WU full-length clones is shown in Fig. 1.
Recovery of recombinant viruses. The full-length genomic cDNAs
were assembled and the recombinant viruses were recovered as previously
described (17, 18). Briefly, JHM.SD and JHM.WU plasmids A through G
were digested with BsmBI and isolated from agarose gels. Equal molar
ratios of each fragment were ligated (about 2 g of DNA total) with T4
DNA ligase overnight at 16°C. The ligatedDNAwas chloroform extracted
and precipitated. In vitro transcription driven by a T7 promoter present
directly upstream of the viral DNA was carried out using the mMessage
FIG 1 MHV genome organization and the full-length JHM.WU and JHM.SD cDNA clones. The full-length viral genomes were amplified as fragments A to G,
which were cloned individually into plasmids. BsmBI type II restriction sites were added to the internal termini of each of the fragments and used for assembly.
A T7 promoter for in vitro RNA transcription was added to the 5= end of fragment A. The full-length genomic cDNAs were assembled in vitro and the viruses
recovered from each designated rSD for JHM.SD and rWU for JHM.WU.
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mMachine T7 transcription kit (Ambion) (17). The nucleocapsid gene
was amplified from each G plasmid with primers bearing the SP6 pro-
moter and then similarly transcribed with the mMessage mMachine SP6
transcription kit. The viral genome transcripts were combined with the N
gene transcripts and electroporated into the BHK-MHVR with three
pulses of 850 V at 25 F using a Gene Pulser II electroporator (Bio-Rad,
Hercules, CA), and these cells were overlaid on nearly confluent L2 cells.
When viral cytopathology was observed, the combined cells and superna-
tant were harvested. Recombinant viruses were plaque purified and am-
plified in 17Cl-1 cells. Recombinant JHM.SDwill be referred to as rSDand
JHM.WU as rWU here.
Generation of chimeric andmutant recombinant viruses.To gener-
ate the chimeric JHM.SD expressing the spike gene ofWU (rSD.SWU), the
portion of the spike gene containing the JHM.WU polymorphism was
amplified from the JHM.WU G fragment and cloned into the AvrII and
SphI sites of the JHM.SD G fragment (see Fig. 3A). The chimeric JHM.
WU with the entire JHM.SD spike gene (rWU.SSD) was constructed by
replacing the BamHI-SphI fragment containing the spike gene. The chi-
meric JHM.SD viruses containing the F and/or G fragment of JHM.WU
were constructed by combining JHM.SD fragments A through E with the
F and/or G fragment from JHM.WU. The resulting viruses were desig-
nated rSD.FWU, rSD.GWU, and rSD.FWUGWU. Similarly, rWU.ASD and
rWU.CSD were generated by replacing the A and C fragments, respec-
tively, of JHM.WU with those of JHM.SD. Single mutations were con-
structed by PCR-based site-directed mutagenesis and verified by nucleo-
tide sequencing.
Viral replication kinetics. L2 or BMM cells were infected with each
virus at a multiplicity of infection (MOI) of 0.01 or 1 PFU/cell, as indi-
cated. After 1 h, the cells were washed and cultured with DMEM supple-
mented with 10% FBS. The culture supernatants were collected at the
indicated time points, and the virus titers were determined by plaque
assays on L2 cells (22).
ELISA. IFN- protein in the supernatant of MHV-infected BMMwas
quantified using a commercial capture enzyme-linked immunosorbent
assay (ELISA) kit (PBL Laboratories, Piscataway, NJ) according to the
manufacturer’s instructions.
Mouse infections. Viruses were diluted into phosphate-buffered sa-
line (PBS) containing 0.75% bovine serum albumin. Four-week-old B6
mice were anesthetized with isoflurane (IsoFlo; Abbott Laboratories) and
inoculated intrahepatically (i.h.) or intracranially (i.c.) with each virus at
the indicated dose. On day 5 postinfection (p.i.), the mice were sacrificed
and perfused with PBS. The livers and/or brains were harvested and ho-
mogenized and their virus titers determined by plaque assays on L2 cells as
previously described (23). All mouse procedures were reviewed and ap-
proved by the University of Pennsylvania IACUC.
Histology.The liverswere isolated andfixed in 4%paraformaldehyde,
embedded in paraffin, and sectioned. Liver sections were stained with
hematoxylin and eosin.
Statistical analysis.A two-tailed Student t test was performed to assess
statistical significance for in vitro experiments. The Mann-Whitney test
was used to analyze differences in virus titer in mouse tissues. Any unde-
tectable titer from in vitro or in vivo infection was entered as the limit of
detection for the corresponding experiment. All data were analyzed using
GraphPad Prism software (GraphPad Software, Inc., CA).
RESULTS
Construction of JHM.SD and JHM.WU reverse genetic systems
and comparisonof recombinant andparentalwild-type viruses.
The construction of the full-length cDNA clones for JHM.SD and
JHM.WU (1) is described in detail in Materials and Methods and
summarized briefly here. Using the genomic RNA of wt recombi-
nant JHM.SD (RJHM/A) previously generated by targeted recom-
bination (24) as a template, seven DNA fragments (A to G) span-
ning the entire genome were amplified and cloned into bacterial
plasmids. A T7 promoter was introduced at the 5= end of the A
fragment (Fig. 1). Cleavage sites for the type II restriction enzyme
BsmBI were introduced at the junction sites of each fragment, and
all endogenous BsmBI sites were removed by introduction of non-
coding mutations (Fig. 1). Other than the nine silent mutations
used to remove the BsmBI sites within the genome, the cloned
fragments are identical to the sequence of JHM.SD (RJHM/A;
GenBank: FJ647219.1). The seven fragments were digested
from vectors and assembled into a full-length genomic cDNA.
Viral RNA was transcribed using the 5= T7 promoter and elec-
troporated into BHK-MHVR cells to generate the recombinant
JHM.SD, which will be referred to herein as rSD.
For construction of the JHM.WU infectious clone, fragments
A, C, F, and G were amplified from JHM.WU (wb-3) genomic
RNAand cloned into bacterial vectors as described above. Because
there were no amino acid difference in the proteins encoded
within the B, D, and E fragments of JHM.WU and JHM.SD, the
JHM.SD fragments were used to complete the full genomic cDNA
of JHM.WU (Fig. 1). Other than the nine silent mutations used
to remove the BsmBI sites, and three synonymous point substitu-
tions in nsp1 and nsp3, the cloned fragments are identical to the
sequence of JHM.WU (JHM.WU; GenBank: JX169867.1). Re-
combinant JHM.WU (referred to as rWU) was recovered as
for rSD.
To compare the phenotypes of rSD and rWU with those of
their parental viruses, we first determined their replication kinet-
ics (at a lowMOI, 0.01 PFU/cell) inmurine L2 fibroblasts. Neither
the kinetics of replication nor the final titer differed between
JHM.SD and its infectious-clone counterpart rSD or between
JHM.WU and rWU (Fig. 2A). Of note, JHM.WU and rWU repli-
cated faster than JHM.SD and rSD and to a peak titer 100- to
1,000-fold higher at 36 h postinfection.
Next, we compared replication of rWU and rSD with that of
their respective parental viruses in vivo in mice. Previous studies
demonstrated that intracranial (i.c.) inoculation of weanling
C57BL/6 (B6) mice with JHM.SD or JHM.WU caused severe en-
cephalitis (13, 15, 16, 25) but that only JHM.WU caused hepatitis
(13, 14). Following i.c. infection of B6 mice, the titer of rSD was
approximately 4.7 106 PFU g1 of brain, similar to that of wild-
type JHM.SD, while rWU, like JHM.WU, replicated to an approx-
imately 10-fold-higher titer (Fig. 2B). In both JHM.SD-infected
and rSD-infected mice, the viral titers in the liver were below the
limit of detection by plaque assay (about 100 PFU g1); in con-
trast, approximately 106 PFUg1 of viruswas detected in the livers
of JHM.WU-infected and rWU-infected mice (Fig. 2B). Follow-
ing intrahepatic (i.h.) inoculation, JHM.WU and rWU replicated
in the liver to an even higher titer, approximately 107 PFU g1,
whereas replication of JHM.SD and rSD was below the level of
detection (Fig. 2C), as previously observed (24). Previous studies
in our lab had indicated that the extent of hepatitis (inflammation
and necrosis) in MHV-infected mice correlates with the extent of
infectious virus replication in the liver (24). Indeed, hematoxylin
and eosin staining demonstrated severe liver necrosis in rWU-
infected mouse liver, while no obvious liver damage was observed
in rSD-infected mice (Fig. 2D). These results indicated that rSD
and rWU reproduced the pathogenesis of their parental isolates
JHM.SD and JHM.WU in the mouse model.
Exchange of the JHM.WU and JHM.SD spike proteins does
not affect replication in the liver. Relative to the JHM.SD spike,
the JHM.WU spike has a 141-amino-acid in-frame deletion
(JHM.SD residues 454 to 594)within the S1 subunit hypervariable
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domain as well as a 1-amino-acid substitution, L48R, within the
receptor-binding domain at the amino terminus of the S1 subunit
(Table 1). To address whether this deletion and mutation affect
liver tropism, we exchanged the spike genes of rSD and rWU to
generate rSD.SWU and rWU.SSD (Fig. 3A) and characterized their
growth kinetics in L2 cells. Compared to rSD, rSD.SWU replicated
to a 10- to 100-fold-higher titer in L2 cells, suggesting that spike
substitution enhanced virus production in vitro (Fig. 3B). Consis-
tent with these data, rWU.SSD displayed a 10- to 100-fold-lower
titer than rWU (Fig. 3D). In contrast to the in vitro results, while
both rSD.Swu and rSD failed to replicate in the liver in B6 mice
(Fig. 3C), rWUand rWU.SSD replicated to similar titers in the liver
in B6 mice (Fig. 3E). Thus, while the spike protein does influence
replication kinetics in vitro, spike is not a significant determinant
of WU liver tropism.
The 3= JHM.WU genome fragments F and G, encoding some
of the nonstructural proteins and all of the structural proteins,
enable JHM.SD to replicate in the liver. After finding that the
JHM.WU spike protein did not enhance rSD replication in the
liver, we investigated which other structural and/or nonstructural
proteinsmight play a role in liver tropism. Thus, we replaced the F
and/or G fragment(s) of JHM.SD with the corresponding frag-
ment(s) of JHM.WU to generate rSD.Gwu, rSD.Fwu, and rSD.
FWUGWU (Fig. 4A). TheG fragment encodesmost of the structural
proteins, including the nucleocapsid, membrane protein (M),
small membrane protein (E), spike, and part of the HE protein
(Fig. 1); the F fragment encodes the rest of the HE protein, acces-
sory protein ns2, and a segment of open reading frame (ORF) 1b
including the carboxy-terminal portion of replicase protein nsp12
as well as all of nsp13 to -16. Replacement of the G fragment alone
or in combination with F conferred efficient replication in L2 cells
in vitro, while rSD.FWU did not replicate to a higher titer than rSD
(Fig. 4B). In contrast, in vivo, replacement of either the F or G
fragment alone only marginally increased rSD replication in the
liver at 5 days postinfection. However, replacement of both the F
and G fragments (rSD.FWUGWU) restored replication to approxi-
TABLE 1 Amino acid differences between JHM.SD and JHM.WU
encoded proteinsa
Fragmentb Proteinc
Amino acid
positiond JHM.SD JHM.WU
A nsp1 194 R K
nsp2 282 V L
326 A V
nsp3 173 P H
C nsp5 262 M V
nsp6 21 F V
F nsp13 335 V A
nsp15 41 E V
ns2 177 D G
HE 3 R S
G HE 408 I V
425 M I
426 F L
Spike 48 L R
454–594 Deletione
M 155 L F
224 A V
a GenBank accession numbers: JHM.SD (RJHM/A), FJ647219.1; JHM.WU (wb-3),
JX169867.1.
b Fragments A, C, F, and G encoded amino acid differences between JHM.SD and
JHM.WU.
c Proteins that contain amino acid polymorphisms are listed.
d The position of the amino acid variation in each protein is shown.
e JHM.WU spike protein contains a 141-amino-acid deletion relative to JHM.SD spike.
FIG 2 Comparison of recombinant and parental wild-type JHM.SD and
JHM.WU in vitro and in vivo. (A) L2 cells were infected (in triplicate) with
JHM.SD, rSD, JHM.WU, and rWU (MOI 0.01 PFU/cell), and supernatants
were collected at the indicated times and the virus titers determined. (B) Mice
(n 7 or 8) were infected i.c. (50 PFU/mouse); on day 5 postinfection, mice
were sacrificed and the virus titers in the brain and liver determined. (C)Mice
(n 5) were infected i.h. (500 PFU/mouse), and the virus titer in the liver on
day 5 postinfection was determined. The dashed lines represent the limit of
detection, and the error bars represent the standard error of the mean (SEM)
(***, P  0.001). (D) Liver sections from mice (n  3) sacrificed on day 5
postinfection were stained with hematoxylin and eosin. One representative
section is shown. The data are from one representative experiment of two.
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mately 2.6105 PFU g1 in the liver, about 10- to 50-fold lower
than that for rWU (Fig. 4C).
The JHM.SD nsp13 and M protein sequences attenuate
JHM.WU replication in vitro and in the liver. To identify which
protein(s) encoded within fragments F and G of JHM.WU is es-
sential to MHV liver replication, we compared the sequences of
the proteins encoded by fragments F and G between the two JHM
strains (Table 1). In addition to the differences in the spike, dis-
cussed above, these included amino acid substitutions in the
structural proteins HE and M (fragment G) and the accessory
protein ns2 and nonstructural replicase proteins nsp13 and
nsp15 (fragment F) (26) (Fig. 5A). To evaluate the importance of
these polymorphisms, we generated recombinant viruses in the
JHM.WU background bearing amino acid substitutions found in
the JHM.SD genome (Fig. 5A). Four of these, rWU.HEV408I,
rWU.HEI425M,L426F, rWU.ns2G177D/HES3R, and rWU.nsp15V41E,
exhibited growth kinetics in L2 cells that were similar to those of
rWU (Fig. 5B and C) and furthermore replicated as efficiently
(i.e., with no significant difference) as rWU inmouse liver (Fig. 5C
and E). (The P value for nsp15 versus wt rWU mouse liver repli-
cation is 0.0952.) Therefore, the sequence differences in HE, ns2,
and nsp15 in the JHM.SD genome did not significantly affect viral
replication in the liver.
In contrast,mutationswithin theMandnsp13 genes conferred
phenotypic changes in vitro and in vivo. Two amino acid differ-
ences were identified between M proteins of JHM.WU and
JHM.SD (Table 1). To determine their impact on viral replication,
we generated recombinant viruses with each or both of the
JHM.SD M substitutions in the rWU background. The recombi-
nant viruses containing single substitutions (rWU.MF155L and
rWU.MV224A) did not replicate significantly differently from rWU
in vitro (Fig. 5B) or in vivo (Fig. 5C). However, the double mutant
rWU.MF155L,V224A showed impaired viral growth kinetics in L2
cells (Fig. 5B), and, likely as a consequence of less robust replica-
tion, an approximately 1,000-fold decrease in the viral load in
the livers of infected mice compared to rWU (Fig. 5C). Simi-
larly, the nsp13 gene of rWU also contributed to efficient rep-
lication in vitro and in vivo. rWU.nsp13A335V, encoding the
nsp13 of JHM.SD, displayed attenuated growth kinetics in L2
cells relative to rWU as well as an approximately 30-fold lower
viral titer in the livers of infected mice. Thus, sequences in the
M and nsp13 proteins of JHM.WU were responsible for the
enhanced replication of rSD.FWUGWU in the liver.
nsp1 does not affect replication in L2 cells in vitro but influ-
ences viral replication in the liver.As described above, fragments
F and G were insufficient for restoring rSD replication in the liver
to the level of rWU, and there were no amino acid differences
between the fragment B-, D-, and E-encoded proteins of JHM.SD
and JHM.WU. These data suggested that WU fragment(s) A
and/or C was likely to contribute to liver replication. To test this,
we generated chimeric viruses in the rWU background in which
fragment A or C was replaced with the corresponding JHM.SD
fragment (Fig. 6A). Both rWU.CSD and rWU.ASD showed growth
kinetics similar to those of rWU in L2 cells; however, rWU.ASD
was also significantly attenuated (approximately 100-fold) for
replication in the liver (Fig. 6B and C). Four amino acid differ-
ences between JHM.WU and JHM.SD were identified in the A
fragment (nsp1, nsp2, and nsp3), and mutations corresponding
to these differences were introduced into the rWU genome to
generate rWU.nsp1K194R, rWU.nsp2L282V, rWU.nsp2V326A, and
rWU.nsp3H173P (Fig. 6A). All four viruses replicated with similar
kinetics and to a similar final titer as rWU in vitro in L2 cells
(Fig. 6B), indicating that polymorphisms in nsp1, nsp2, or nsp3
had no detectable effect on in vitro replication.
While there were no detectable effects on liver replication ob-
served during infection with nsp2 or nsp3 mutants, attenuation
of liver replication (approximately 100-fold)was observed inmice
infected with rWU.nsp1K194R compared with rWU (Fig. 6C).
rWU.nsp1K194R replicated in the liver to a similar extent as rWU.
ASD and rSD.FWUGWU (which contains fragments A through E
from rSD), indicating that the nsp1 amino acid substitution alone
is sufficient to account for the attenuation (relative to rWU) of the
latter two chimeric viruses. To further investigate the impact of
nsp1 residue 194 on pathogenesis, the reverse substitution was
introduced into the rSD genome to generate rSD.nsp1R194K. Sim-
FIG 3 Replication of spike-exchanged recombinant viruses in vitro and in vivo.
(A)Schematicdiagramof recombinantviral genomeswithexchanged spikegenes.
(B andD)L2 cellswere infected (in triplicate,MOI 0.01PFU/cell)with rSDand
rSD.SWU (B) or rWU and rWU.SSD (D), and the supernatant was collected at the
indicated time points postinfection for determination of the viral titer. (C and E)
Mice (n 4 or 5)were infected i.h. with 500 PFU/mouse of rSD and rSD.SWU (C)
or rWUand rWU.SSD (E) andwere sacrificed onday 5 postinfection, and the viral
titer in the liver was determined. The dashed lines represent the limit of detection.
The error bars represent the SEM (ns, nonsignificant). The data are from one
representative experiment of two.
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ilar in vitro growth kinetics was observed for rSD.nsp1R194K and
rSD in L2 cells (Fig. 6D). However, rSD.nsp1R194K replicated to a
significantly higher titer in mouse liver (Fig. 6E) (rSD was unde-
tectable, as in previous figures). As the nsp1 residue K194 is con-
served among all MHV strains except JHM.SD (see Fig. 8 and
Discussion), the sameK194R substitutionwas introduced into the
genome of recombinant A59 (rA59), another hepatotropic strain
used frequently for MHV pathogenesis studies, to generate
A59.nsp1K194R. The A59.nsp1K194R mutant replicated similarly to
rA59 in vitro but showed attenuated (near 100-fold) liver replica-
tion (Fig. 6F and G). To further understand the impact of muta-
tions in nsp1, we constructed mutant virus A59.nsp1R193S/K194E
with substitutions introducing charge alterations into nsp1,
analogous to a SARS nps1 reported in the literature (27). How-
ever, the double mutant had a phenotype similar to that of the
single mutant A59.nsp1K194R in terms of replication both in
vitro in L2 cells and in vivo in the liver (Fig. 6F and G). More-
over, the same double substitution was introduced into nsp1 of
rWU (rWU.nsp1R193S/K194E); as for rA59, no difference was ob-
served between the single and double mutants in replication in
either L2 cells or the liver (data not shown). These data suggest
that mutation of the conserved K194 decreases virulence with-
out affecting in vitro replication.
The nsp1 protein antagonizes IFN- production during
MHV infection.Previous studies showed that theMHVnsp1 pro-
tein might be involved in antagonizing the type I IFN immune
response (27, 28). To investigate whether the IFN responsemay be
involved in the phenotype of our nsp1 mutants, we compared the
replication as well as the IFN- production of both rWUand rA59
with those of their respective nsp1K194R mutants in bonemarrow-
derived macrophages (BMM), one of the few cell types in which
MHV elicits a type I IFN response (29, 30). The rA59.nsp1K194R
andA59.nsp1R193S/K194Emutants replicated similarly, albeit to a 6-
to 10-fold-lower titer than for rA59 by 24 h postinfection (Fig.
7A). However, the replication of bothmutants was restored in the
absence of IFN signaling, i.e., during replication in BMM derived
from IFNAR/mice (Fig. 7B). A similar patternwas observed for
induction of IFN- expression upon infection: BMM infected
with wt rA59 produced approximately 210 pg ml1 of IFN- in
the culture supernatant, whereas those infected with the
rA59.nsp1K194R mutant produced 3,000 pg ml1 of IFN-, pre-
sumably resulting in more robust antiviral activity. Interestingly,
the effects of these mutations were less pronounced in the rWU
background. We observed no difference in replication between
rWU and either rWU-nsp1K194R or rWU.nsp1R193S/K194E (Fig.
7D), and the difference in IFN- productionwas also smaller (Fig.
7F): while BMM infected with rWU produced no detectable
IFN- in the culture supernatant, those infected with rWU-
nsp1K194R produced 140 pg ml1 (Fig. 7F). Consistent with these
findings, BMM infected with rSD-nsp1R194K induced 12-fold less
IFN- than those infected with wt rSD (Fig. 7G). Thus, the con-
served nsp1 K194 residue found in the hepatotropic rWU and
rA59, while not important for replication in the L2 cell line in
vitro, was associatedwith lower IFN- production in BMMaswell
as higher liver titers.
DISCUSSION
Infection of mice with laboratory strains of MHV causes hepatitis
and encephalitis in a strain-specific manner. JHM.SD and JHM.
WU are very closely related isolates with strikingly different in
vitro replication and in vivo hepatovirulence phenotypes, likely
reflecting the passage history of the two isolates since their deriva-
tion from the same JHM isolate, which had been brain adapted by
many serial passage through suckling mouse brains (31). MHV-4
(from which recombinant JHM.SD was derived) was plaque
purified from the mouse brain-passaged virus, while JHM.WU
(wb-3) was serially passaged 20 times in tissue culture before
plaque purification (5, 15, 16, 32). The passage history coupled
with data presented here suggest that adaptation to mouse brain
may select for variants unable to replicate efficiently in tissue cul-
ture or in the liver. This is consistent with our previous work in
FIG4 Partial restoration of the replication of chimeric rSD viruses in the liver by replacement of F and/orG fragmentswith those of rWU. (A) Schematic diagram
of the chimeric rSD viruses expressing the F or/andG fragment of rWU. (B) L2 cells were infected (in triplicate,MOI 0.01 PFU/cell) and supernatants collected
at the indicated time points postinfection for determination of the viral titer. (C) Mice (n  5) were infected i.h. (500 PFU/mouse) and sacrificed on day 5
postinfection, and the viral titer in the liver was determined. The dashed line represents the limit of detection. The error bars represent the SEM (**, P 0.01).
The data are from one representative experiment of two.
JHM Hepatotropism Maps to nsp1, nsp13, and M
April 2015 Volume 89 Number 7 jvi.asm.org 3603Journal of Virology
which nonhepatotropic variants of rA59 were selected by passage
in primary glial cell cultures (22, 23).
Using reverse genetic systems, we constructed chimeric recom-
binant viruses and used them to identify the JHM.WU-encoded
determinants of efficient replication in tissue culture and of liver
pathogenesis. There were remarkably few amino acid differ-
ences between the proteins encoded by these two viruses. The
3= third of the JHM.WU genome, encoding the structural pro-
teins, was necessary for efficient in vitro replication, whereas
replication to a high titer in the liver was multifactorial and
mapped to amino acid substitutions in the membrane (M)
structural protein as well as in nonstructural replicase proteins
(nsp1 and nsp13) (27, 28, 33).
We initially hypothesized that the spike protein, which is re-
sponsible for receptor binding and viral entry, would define the
difference in tropism between JHM.SD and JHM.WU. Indeed,
numerous past studies demonstrated that sequences in several do-
mains of the MHV spike impact tropism and virulence (8, 16,
34–37). The high neurovirulence of JHM.SD has been associated
with the long hypervariable domain in the S1 subunit of the JHM
spike protein (7, 34). Surprisingly, JHM.WU is highly neuroviru-
lent despite the 141-amino-acid deletion in the hypervariable do-
main, and our data indicate that the JHM.WU spike does not
confer hepatotropism; although the JHM.WU spike enhanced
replication of rSD.SWU to some extent in cell culture (Fig. 3B and
D), there was no significant effect on replication in the liver (Fig.
3C and E). Similarly, a chimeric rSD expressing the spike of hepa-
totropic MHV-A59 was not able to replicate in the liver (13).
These results indicated that MHV replication in the liver is
largely determined by postentry events and that attenuation of
FIG 5 Amino acid substitutions in the nsp13 and M proteins attenuate rWU replication. (A) Schematic diagram of the rWU genome showing the amino acid
differences from JHM.SD in the F and G fragments. (B and D) L2 cells were infected (in triplicate, MOI 0.01 PFU/cell) with viruses with mutations in the G
fragment (B) or F fragment (D), and supernatant was collected at the indicated times postinfection for determination of the virus titer. (C and E) B6 mice (n
5) were infected i.h. (500 PFU/mouse) with viruses withmutations in the G fragment (C) or F fragment (E). On day 5 postinfection, themice were sacrificed and
the virus titer in the liver determined. The dashed lines represent the limit of detection. The error bars represent the SEM (ns, nonsignificant; **, P 0.01). The
data are from one representative experiment of two.
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replication in vitro may not predict poor viral replication in
vivo. Interestingly, while JHM.SD replicates poorly in vitro and
minimally in the liver, it replicates well in the central nervous
system, where it spreads extensively and efficiently throughout
the brain, in multiple cell types, even in the absence of the only
known MHV receptor, CEACAM1a (38, 39). While difficult to
explain on a mechanistic level, this likely reflects a very strong
selection for the ability to replicate in the brain resulting from
serial brain passage.
Themembrane protein (M), themost abundant component of
the virion, is key to viral particle assembly through interactions
with spike (40) and nucleocapsid (41) as well asM-M interactions
(42) and may, in addition, interact with the viral RNA (43, 44)
through the carboxy-terminal tail of the protein. Consistent with
the role of M in virus assembly, an M protein mutant of SARS-
CoV, selected by serial passage in primary human renal tubular
epithelial cells, was associated with persistent infection and en-
hanced virus production (45). The combined introduction of two
JHM.SD amino acid substitutions together into the carboxy-ter-
minal endodomain of rWU M protein (rWU.MF155L,V224A) im-
paired replication in L2 cells and quite dramatically in the mouse
liver, although neither substitution alone conferred any detect-
able phenotype (Fig. 5). While rWU.MF155L,V224A replicated
moderately less well than rWU in L2 cells, it was about 1,000-
fold attenuated in the liver, suggesting that other virus-host
interactions in addition to virus assembly were contributing to
the loss of replication in the liver. Interestingly, a study of
MHV-A59 M protein glycosylation variants correlated replica-
tion in the liver with induction of type I interferon (46). Future
studies will address whether mutations within M (as well as
nsp1 [discussed below]) contribute to the differences observed
in IFN production during JHM.SD versus JHM.WU infection
of BMM (Fig. 7F and G).
We also identified amino acid differences between the JHM.SD
and JHM.WU genomes within nonstructural proteins (Table 1).
Among these, only the JHM.SD-specific amino acid substitu-
tions in nsp1 and nsp13 influenced the phenotype. Introduc-
tion of an A335V substitution into the helicase domain of
FIG 6 A single amino acid substitution in nsp1 attenuates the replication of rWU and rA59 in the liver. (A) Schematic diagram of the chimeric rWU viruses with
the C or A fragment of rSD or with point substitutions in the A fragment. (B, D, and F) L2 cells were infected (in triplicate) at an MOI of 0.01 PFU/cell for the
rWU background viruses or 1 PFU/cell for the rA59 background viruses, and supernatant was collected at the indicated times postinfection for determination of
the viral titer. (C, E, and G)Mice (n 5) were infected i.h. with 500 PFU/mouse for the rWU background viruses and rSD.FWUGWU (C), 10,000 PFU/mouse for
the rSD viruses (E), or 5,000 PFU/mouse for the rA59 background viruses (G). On day 5 postinfection, mice were sacrificed and the viral titer in the liver was
determined. The dashed lines represent the limit of detection. The error bars represent the SEM (ns, nonsignificant; *, P 0.05; **, P 0.01). The data are from
one representative experiment of two.
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JHM.WU nsp13 attenuates viral replication both in vitro and in
vivo (47) (Fig. 5). As the A335V substitution confers less effi-
cient replication in vitro, it is likely that the in vivo effects are
due to less efficient replication. Consistent with a role of nsp13
in contributing to efficient replication, nsp13 mutations were
identified during the emergence of SARS-CoV into the human
population and in mouse-adapted strains, which replicate
more efficiently in the lung (48, 49).
Nsp1 is the N-terminal cleavage product of the replicase poly-
protein and is encoded by all betacoronaviruses.While nsp1 varies
in length, from 247 residues in MHV to 175 in bat CoV-HKU9,
certain regions are conserved (20). The K194 residue of MHV
nsp1 is located in a positively charged domain (LLRK194GGNKG),
is relatively conserved among betacoronaviruses (Fig. 8), and is
presumed to be involved in RNA binding and/or protein-protein
interactions (50, 51). The K194 residue ofMHVnsp1 is conserved
among all MHV isolates except JHM.SD (with its K194R substi-
tution) and also throughout other betacoronaviruses (Fig. 8). We
FIG 7 nsp1 antagonizes IFN- production. BMM derived from B6 (A and D) or IFNAR/ (B and E) mice were infected (MOI  1 PFU/cell) with each
virus, and supernatant was collected at the indicated time points postinfection for determination of the viral titer. B6 BMM were infected (MOI  2
PFU/cell [C and F] and 1 PFU/cell [G]) with the indicated viruses, and at 24 h postinfection, IFN- protein in the B6 BMM supernatants was quantified
by ELISA. The dashed lines represent the limit of detection. The data are from one representative experiment of two (each performed in triplicate). ND,
not detectable.
FIG 8 Sequence alignment of the Betacoronavirus nsp1 region surrounding lysine 194. nsp1 sequences of the representative Betacoronavirus strains from
subgroup 2a through 2dwere aligned using CLUSTAL 2.1. Completely conserved residues are in black boxes, and partially conserved residues are in white boxes.
The positively charged conserved domain is underlined, and MHV residue 194 is indicated by the black triangle. GenBank accession numbers are as follows:
JHM.SD (RJHM/A), FJ647219.1; JHM.WU (wb-3), JX169867.1; A59 (RA59/R13), FJ647218.1; MHV-3, FJ647224.1; MHV-2, AF201929.1; MHV-1, FJ647223.1;
BCoV-Mebus (bovine coronavirusMebus strain), U00735.2; HCoV-OC43 (human coronavirus OC43), NC_005147.1; SARS-CoV (SARS coronavirus CFB/SZ/
94/03), AY545919.1; MERS-CoV (MERS coronavirus EMC/2012), JX869059.2; BtCoV-133 (bat coronavirus 133/2005), NC_008315.1; BtCoV-HKU9-1 (bat
coronavirus HKU9-1), NC_009021.1.
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found that neither K194R nor the charge-disrupting R193S/
K194E double substitution within JHM.WU had a detectable ef-
fect on replication in vitro; however, both substitutions conferred
approximately 100-fold attenuated replication in vivo. Intro-
duction of the K194R or R193S/K194E substitutions into an-
other hepatotropic strain, rA59, had similar attenuating effects
on liver replication. Conversely, the R194K substitution in the
nsp1 of rSD confers a detectable albeit low level of virus repli-
cation in the liver.
Previous studies have reported an impaired and delayed type I
interferon (IFN) response during in vitro infection by MHV,
SARS-CoV, or MERS-CoV (52–55) and that this may in part be
conferred by nsp1 (20). Data from our lab suggested that MHV-
A59 inhibits IFNprotein production at the translational level (53).
In other studies, MHV-A59 mutants either with a deletion of the
LLRK194GGNKG domain (56) or with an internal downstream
33-amino-acid in-frame deletion (28) were attenuated for liver
replication as well as the onset of hepatitis in wild-typemice, while
the latter deletion mutant recovered replication in type I IFN re-
ceptor expression-deficient (IFNAR/) mice (28). In addition,
transient expression of MHV or SARS-CoV nsp1 significantly re-
duced expression of a luciferase reporter gene under the control of
the IFN- or IFN-stimulated response element (ISRE) promoter
(28), implying that nsp1 may antagonize the type I interferon
signaling pathway. Furthermore, the importance of residues
R193/K194 for virulence via IFN antagonism is supported by the
finding that a SARS-CoVmutant expressing nsp1with amino acid
substitutions of these conserved residues (R124S/K125E, corre-
sponding to residues 193/194 of MHV nsp1) was more sensitive
than wt virus to type I IFN treatment (27). In another group of
studies, the nsp1 of SARS-CoV was reported to promote mRNA
degradation and to inhibit protein translation, thereby inhibiting
IFN- production at both the mRNA and protein levels (33, 57–
60), while an nps1mutant (R124A/K125A) was unable to degrade
mRNA but retained the ability to inhibit protein synthesis. Thus,
the effects of nsp1 on transcription and translation are complex
and may be coronavirus strain type dependent (20).
Interestingly, the attenuation phenotype conferred by muta-
tion of nsp1 is observed only in the livers of infected mice and not
in the brains. In our studies following intracranial infection, while
rWU.nsp1K194 was significantly attenuated for liver replication
compared to rWU, there were no significant differences observed
in replication of the two viruses in the brain (data not shown).
This is similar to the phenotype of an A59 ns2 PDEmutant, which
replicates robustly in the brain while being highly attenuated for
liver replication and hepatitis (12, 30). The liver-specific attenua-
tion of these mutants, both deficient in type I IFN antagonism, is
likely explained by our previous finding that basal levels of inter-
feron-stimulated gene expression are much higher in the liver
than in the brain, leading to amore robust host innate response in
the liver than in the brain (14, 30) Themechanism bywhichMHV
nsp1 interferes with the type I IFN response and its role in liver
tropism are not yet well understood andwill be a subject of further
investigation.
Elucidating themechanisms underlying tropism and virulence
using these model coronaviruses may also contribute to our
knowledge of the pathogenesis of the human-pathogenic corona-
viruses such as SARS-CoV or MERS-CoV, as the LRKGGNKG
motif of nsp1 as well as the nsp13 helicase and M protein are
conserved among these viruses. Understanding these virulence
determinants may in the long term contribute to the design of live
attenuated vaccines for coronaviruses.
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